CADASIL is one of the most common genetic causes of stroke and dementia. Currently there is no treatment for CADASIL. In this study, human stem cells will be generated from a piece of skin donated by patients with CADASIL. From these stem cells, smooth muscle cells (SMCs) will be generated in a tissue culture dish in the lab.
Our new report, ‘Current, future and avoidable costs of stroke in the UK’, suggests that investing in stroke research today could lead to a significant reduction in the burden of stroke in the future.
We need your support to continue to invest in research that will help to save lives and enable stroke survivors to make the best possible recovery.
The aim of this research programme is to develop a human brain bank to support biomedical research into the pathophysiology of human SVD that may be used nationally and internationally.
People with stroke due to brain haemorrhage have swelling around the haemorrhage on their brain scan. More swelling worsens recovery. No treatment improves outcome after this swelling.
The programme will use biological information about cells and molecules, and information from patients, to design a study of treatment for swelling after brain haemorrhage.
The Stroke Association's Keynote Lecture is a prestigious event that showcases the latest advancements being made in stroke research.
Find out more about our Keynote Lecture 2015
Project Grants are our most popular funding stream and cover the whole spectrum of stroke research - from prevention and risk factors, through to treatment and rehabilitation in a clinical setting and longer-term in the community. Find out more about our project grants awarded for 2016.